Liyan Xu

49PUBLICATIONS
153CO-AUTHORS
Predictive and prognostic markersEpidemiological methodsMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Oct 15, 2026
Plasma autoantibody profiling via PhIP-seq and machine learning for diagnosis of esophageal squamous cell carcinoma.

|Sep 22, 2026
Large-scale esophageal cancer screening through noncontrast computed tomography and artificial intelligence.

|Apr 13, 2026
IL1RAP Antibody-Drug Conjugates Potently Target Primary and Metastatic Diseases in Multiple Oncofusion-Driven Cancers.

Hai-Feng Zhang, Edouard De Dreuzy, Yue Zhou Huang

|Nov 22, 2025
Integrating multi-omics to reveal the molecular mechanism of lipid metabolism regulated by a splice variant of Lysyl-oxidase like-2, LOXL2Δ13.

Yang Chen, Liu Peng, Jian-Zhong He

|Oct 07, 2025
Serum multiomics prediction of prognosis and adverse reactions to concurrent chemoradiotherapy in patients with esophageal cancer.

Wen-Zhi Wu, He-Cheng Huang, Guang-Hui Zhu

|Sep 02, 2025
SOX2 drives esophageal squamous carcinoma by reprogramming lipid metabolism and histone acetylation landscape.

Zhen Wang, Ruofei Dai, Li Kang

Pageof 9

Frequent Collaborators

35 joint publications

Enmin Li

4 joint publications

Qing-Feng Huang

4 joint publications

Jiemin Wong

3 joint publications

Lin Long